GLP-1 medicines have changed the way many people with type 2 diabetes are treated. These medicines can lower blood sugar, reduce appetite, support weight loss and, for selected medicines and patients, provide important cardiovascular and kidney benefits.
But a common question patients ask is:
“Do I need a GLP-1 medicine if I have diabetes?”
The answer depends on your blood sugar levels, weight, cardiovascular and kidney health, other medications, side effects, affordability and individual treatment goals.
The 2026 American Diabetes Association (ADA) Standards of Care recognize GLP-1 receptor agonists and dual GIP/GLP-1 medicines as highly effective options for appropriate people with type 2 diabetes.
What are GLP-1 medicines?
GLP-1 stands for glucagon-like peptide-1. It is a naturally occurring hormone involved in blood sugar regulation and appetite control.
GLP-1 receptor agonists mimic some of the effects of this hormone. They can:
- Increase insulin secretion when blood glucose is elevated
- Reduce glucagon secretion
- Slow stomach emptying
- Increase fullness and reduce appetite
- Lower blood glucose
- Help with weight loss
Because insulin secretion is glucose-dependent, GLP-1 medicines generally have a relatively low risk of hypoglycemia when used alone or with medicines that do not independently cause hypoglycemia.
Which GLP-1 medicines are used in diabetes?
Examples of GLP-1-based therapies include:
- Semaglutide
- Dulaglutide
- Liraglutide
- Exenatide
There is also tirzepatide, which is a dual GIP and GLP-1 receptor agonist rather than a pure GLP-1 receptor agonist.
Semaglutide is available in both injectable and oral formulations in some settings, while many other GLP-1 medicines are administered by injection. Availability and approved indications vary by country and product.
How do GLP-1 medicines lower blood sugar?
GLP-1-based medicines work through several mechanisms.
1. They increase insulin secretion
When blood glucose is elevated, GLP-1-based medicines stimulate the pancreas to release more insulin.
2. They reduce glucagon
Glucagon increases glucose production by the liver. GLP-1 activity reduces inappropriate glucagon secretion, helping decrease blood glucose.
3. They slow gastric emptying
Food moves more slowly from the stomach into the intestine, which can reduce the speed at which glucose enters the bloodstream.
4. They reduce appetite
People often feel fuller sooner and may naturally consume fewer calories.
This combination explains why these medicines can improve both diabetes control and body weight.
What are the benefits of GLP-1 medicines in diabetes?
1. Better blood sugar control
GLP-1 medicines can significantly reduce HbA1c in many people with type 2 diabetes.
The amount of reduction depends on the specific medicine, dose, baseline HbA1c and other medications being used.
2. Weight loss
Unlike several older diabetes medicines that can cause weight gain, GLP-1-based therapies generally promote weight loss.
The ADA 2026 Standards specifically recommend prioritizing medications with beneficial effects on weight in people with type 2 diabetes and overweight or obesity.
3. Cardiovascular benefits
Some GLP-1 receptor agonists have demonstrated cardiovascular benefits.
For people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk, the treatment plan may include a GLP-1 receptor agonist and/or an SGLT2 inhibitor with demonstrated cardiovascular benefit, irrespective of whether the person’s HbA1c is already at target.
4. Kidney benefits
GLP-1 medicines may also have an important role in selected people with diabetes and chronic kidney disease.
The ADA 2026 recommends an SGLT2 inhibitor or a GLP-1 receptor agonist with demonstrated benefit in appropriate people with type 2 diabetes and chronic kidney disease.
5. Potential liver benefits
People with type 2 diabetes frequently have metabolic dysfunction-associated steatotic liver disease (MASLD).
GLP-1-based treatment may be considered in selected people with diabetes, overweight/obesity and MASLD, particularly when weight loss and metabolic improvement are also treatment goals.
Can GLP-1 medicines replace insulin?
Sometimes, but not always.
The answer depends on how severe the diabetes is.
For adults with type 2 diabetes without severe hyperglycemia or a hyperglycemic crisis, the 2026 ADA Standards prefer GLP-1-based therapy over insulin when initiating or adding glucose-lowering therapy.
However, insulin should be considered when blood glucose is very high, particularly when:
- HbA1c is >10%
- Blood glucose is ≥300 mg/dL
- There are significant symptoms of hyperglycemia
- There is unexplained weight loss or other evidence of catabolism
- There is a hyperglycemic crisis
In such situations, insulin may be necessary initially. Once glucose toxicity improves, the treatment plan can sometimes be simplified.
Can someone take a GLP-1 medicine along with insulin?
Yes.
In appropriate people with type 2 diabetes who require insulin, adding a GLP-1 receptor agonist or dual GIP/GLP-1 medicine can improve glucose control while providing weight-related benefits and potentially reducing some of the treatment burden associated with insulin intensification.
However, insulin doses may need adjustment to reduce the risk of hypoglycemia.
This should be done under medical supervision rather than stopping or reducing insulin independently.
What are the common side effects?
The most common side effects are gastrointestinal.
They may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Reduced appetite
- Feeling full quickly
These symptoms are often more noticeable when treatment is started or the dose is increased.
Starting at an appropriate dose and gradually increasing it can improve tolerability. Dietary measures such as eating smaller meals and avoiding very large, high-fat meals may also help.
Are GLP-1 medicines completely safe?
No medicine is completely risk-free.
GLP-1-based treatments require individual assessment.
Important considerations include:
Pancreatitis
Acute pancreatitis has been reported in people receiving GLP-1 receptor agonists. If pancreatitis is suspected, the medicine should be stopped and the patient evaluated.
Gallbladder disease
Gallstones and gallbladder-related problems can occur, particularly in the setting of substantial or rapid weight loss.
Severe gastrointestinal problems
These medicines can significantly slow gastric emptying. They are generally not recommended in people with significant gastroparesis.
Diabetic retinopathy
Rapid improvement in glucose control can be associated with worsening diabetic retinopathy in some high-risk individuals, so patients with established retinopathy may require appropriate ophthalmic monitoring.
Thyroid C-cell tumor warning
Some GLP-1 receptor agonists carry warnings related to thyroid C-cell tumors based on findings in rodents. The relevance of these findings to humans has not been established. Individual product prescribing information should be reviewed before treatment.
Who may benefit most from GLP-1 medicines?
GLP-1-based treatment can be particularly useful when type 2 diabetes occurs together with:
- Overweight or obesity
- Poor glucose control
- Cardiovascular disease or high cardiovascular risk
- Chronic kidney disease
- MASLD/MASH in appropriate patients
- A need to minimize weight gain
- A need for more effective glucose lowering without increasing hypoglycemia risk
The choice should always be individualized.
The ADA emphasizes considering glycemic goals, weight goals, cardiovascular disease, kidney disease, liver disease, hypoglycemia risk, side effects, cost, access and patient preferences when choosing diabetes medicines.
Do all people with diabetes need GLP-1 medicines?
No.
GLP-1 medicines are not automatically required for every person with diabetes.
Some people can achieve excellent diabetes control with lifestyle modification, metformin, SGLT2 inhibitors or other appropriate medicines.
For others, a GLP-1-based medicine may provide substantially greater benefit, particularly when obesity, cardiovascular disease, kidney disease or difficult-to-control blood glucose is present.
The goal is not simply to prescribe the newest medicine.
The goal is to choose the right medicine for the right patient.
Can GLP-1 medicines be used only for weight loss?
Some GLP-1-based medicines are approved for chronic weight management in people who meet appropriate criteria, while other products are approved specifically for diabetes.
Importantly, the same active ingredient may be marketed under different brand names and indications.
Therefore, patients should not assume that a medicine prescribed for another person is appropriate for them.
WHO also emphasizes that GLP-1 therapies should be prescribed by an appropriately qualified medical practitioner after considering the individual’s health history and clinical indications.
Can GLP-1 medicines cure diabetes?
No.
GLP-1 medicines can substantially improve diabetes control and may produce significant weight loss in appropriate patients, but they should not be described as a universal “cure” for type 2 diabetes.
Some people who achieve substantial and sustained weight loss may experience diabetes remission, particularly early in the course of disease.
However, remission is different from cure, and blood glucose needs to continue to be monitored.
What happens if you stop a GLP-1 medicine?
This depends on why the medicine was prescribed and what other treatments are being used.
When GLP-1-based obesity pharmacotherapy is stopped, weight regain can occur, and cardiometabolic risk factors may worsen again. The ADA therefore considers obesity pharmacotherapy to be chronic treatment when it is indicated, unless there is a reason to discontinue or change therapy.
For a person with diabetes, stopping a GLP-1 medicine may also lead to deterioration in blood glucose control.
Therefore, do not stop GLP-1 treatment without discussing it with your endocrinologist.
GLP-1 medicines and lifestyle: Do you still need diet and exercise?
Absolutely.
GLP-1 medicines work best as part of a comprehensive diabetes management plan.
A healthy approach includes:
- Protein-rich, balanced meals
- More vegetables and fiber-rich foods
- Appropriate portions of carbohydrates
- Regular physical activity
- Resistance training
- Adequate sleep
- Limiting sugar-sweetened beverages
- Avoiding excessive ultra-processed foods
- Regular monitoring of blood glucose and HbA1c
Medication should complement healthy lifestyle habits rather than replace them.
GLP-1 medicines: frequently asked questions
Is GLP-1 good for type 2 diabetes?
Yes. GLP-1-based medicines can be highly effective for appropriate people with type 2 diabetes, particularly when glucose lowering and weight management are both important.
Can a person with diabetes take GLP-1 medicine if HbA1c is already controlled?
Possibly. Treatment decisions should consider more than HbA1c. For example, cardiovascular or kidney benefits may be relevant in selected patients.
Do GLP-1 medicines cause low sugar?
GLP-1 medicines alone generally have a low risk of hypoglycemia. However, the risk can increase when they are combined with insulin or certain insulin-releasing medicines.
Can GLP-1 medicines cause weight loss?
Yes. Weight loss is one of their important benefits, although the amount varies considerably between medicines and individuals.
Can GLP-1 medicines be taken with metformin?
Yes. GLP-1-based medicines and metformin can be used together when clinically appropriate.
Can GLP-1 medicines be combined with an SGLT2 inhibitor?
Yes. In selected patients, combining these classes can provide complementary glucose, cardiovascular, kidney and metabolic benefits.
Can GLP-1 medicines be taken with a DPP-4 inhibitor?
Generally, combining a GLP-1 receptor agonist with a DPP-4 inhibitor is not recommended, because there is little additional glucose-lowering benefit from the combination.
Do GLP-1 medicines replace a healthy diet?
No. Nutrition and physical activity remain important components of diabetes management.
The Bottom Line
GLP-1 medicines are an important advancement in the treatment of type 2 diabetes.
They can help:
✓ Lower HbA1c
✓ Reduce appetite
✓ Promote weight loss
✓ Reduce the need for some other glucose-lowering medicines
✓ Provide cardiovascular benefits with selected agents
✓ Provide kidney benefits with selected agents
✓ Address diabetes and obesity together
But GLP-1 medicines are not suitable for everyone.
The right treatment depends on your diabetes duration, HbA1c, body weight, kidney and liver health, cardiovascular risk, other medications, side-effect profile, affordability and personal treatment goals.
If you have diabetes and are wondering whether a GLP-1 medicine is appropriate for you, an individualized assessment by an endocrinologist is the safest approach.
Consult Dr. Moxit Shah, DM Endocrinologist in Ahmedabad
If you are struggling with type 2 diabetes, obesity, high HbA1c, insulin resistance or difficulty controlling blood sugar, GLP-1-based treatment may be one of the options to consider.
Dr. Moxit Shah, DM Endocrinologist
Ahmedabad, Gujarat
For appointments: +91 99799 92797
